117 related articles for article (PubMed ID: 12620947)
1. Sevoflurane degradation by carbon dioxide absorbents may produce more than one nephrotoxic compound in rats.
Stabernack CR; Eger EI; Warnken UH; Förster H; Hanks DK; Ferrell LD
Can J Anaesth; 2003 Mar; 50(3):249-52. PubMed ID: 12620947
[TBL] [Abstract][Full Text] [Related]
2. Degradation products of different water content sevoflurane in carbon dioxide absorbents by gas chromatography-mass spectrometry analysis.
Li Y; Li YC; Zhang YN; Liu SJ; Zhou YM; Wang CS; Gong YL; Li EY
Chin Med J (Engl); 2011 Apr; 124(7):1050-4. PubMed ID: 21542967
[TBL] [Abstract][Full Text] [Related]
3. Compound A and carbon monoxide production from sevoflurane and seven different types of carbon dioxide absorbent in a patient model.
Keijzer C; Perez RS; de Lange JJ
Acta Anaesthesiol Scand; 2007 Jan; 51(1):31-7. PubMed ID: 17096668
[TBL] [Abstract][Full Text] [Related]
4. Amsorb Plus and Drägersorb Free, two new-generation carbon dioxide absorbents that produce a low compound A concentration while providing sufficient CO2 absorption capacity in simulated sevoflurane anesthesia.
Kobayashi S; Bito H; Morita K; Katoh T; Sato S
J Anesth; 2004; 18(4):277-81. PubMed ID: 15549470
[TBL] [Abstract][Full Text] [Related]
5. Production of compound A and carbon monoxide in circle systems: an in vitro comparison of two carbon dioxide absorbents.
Struys MM; Bouche MP; Rolly G; Vandevivere YD; Dyzers D; Goeteyn W; Versichelen LF; Van Bocxlaer JF; Mortier EP
Anaesthesia; 2004 Jun; 59(6):584-9. PubMed ID: 15144299
[TBL] [Abstract][Full Text] [Related]
6. Compound A concentration is decreased by cooling anaesthetic circuit during low-flow sevoflurane anaesthesia.
Osawa M; Shinomura T
Can J Anaesth; 1998 Dec; 45(12):1215-8. PubMed ID: 10051944
[TBL] [Abstract][Full Text] [Related]
7. Only carbon dioxide absorbents free of both NaOH and KOH do not generate compound A during in vitro closed-system sevoflurane: evaluation of five absorbents.
Versichelen LF; Bouche MP; Rolly G; Van Bocxlaer JF; Struys MM; De Leenheer AP; Mortier EP
Anesthesiology; 2001 Sep; 95(3):750-5. PubMed ID: 11575550
[TBL] [Abstract][Full Text] [Related]
8. Quantitative differences in the production and toxicity of CF2=BrCl versus CH2F-O-C(=CF2)(CF3) (compound A): the safety of halothane does not indicate the safety of sevoflurane.
Eger EI; Ionescu P; Laster MJ; Gong D; Weiskopf RB; Kerschmann RL
Anesth Analg; 1997 Nov; 85(5):1164-70. PubMed ID: 9356119
[TBL] [Abstract][Full Text] [Related]
9. Dehydration of Baralyme increases compound A resulting from sevoflurane degradation in a standard anesthetic circuit used to anesthetize swine.
Steffey EP; Laster MJ; Ionescu P; Eger EI; Gong D; Weiskopf RB
Anesth Analg; 1997 Dec; 85(6):1382-6. PubMed ID: 9390613
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether ("compound A") in rats.
Kharasch ED; Schroeder JL; Bammler T; Beyer R; Srinouanprachanh S
Toxicol Sci; 2006 Apr; 90(2):419-31. PubMed ID: 16384817
[TBL] [Abstract][Full Text] [Related]
11. Performance of four carbon dioxide absorbents in experimental and clinical settings.
Yamakage M; Takahashi K; Takahashi M; Satoh JI; Namiki A
Anaesthesia; 2009 Mar; 64(3):287-92. PubMed ID: 19302642
[TBL] [Abstract][Full Text] [Related]
12. Carbon dioxide absorbents containing potassium hydroxide produce much larger concentrations of compound A from sevoflurane in clinical practice.
Yamakage M; Yamada S; Chen X; Iwasaki S; Tsujiguchi N; Namiki A
Anesth Analg; 2000 Jul; 91(1):220-4. PubMed ID: 10866916
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of compound A by renal cysteine-S-conjugate beta-lyase is not the mechanism of compound A-induced renal injury in the rat.
Martin JL; Laster MJ; Kandel L; Kerschmann RL; Reed GF; Eger EI
Anesth Analg; 1996 Apr; 82(4):770-4. PubMed ID: 8615496
[TBL] [Abstract][Full Text] [Related]
14. Novel radiator for carbon dioxide absorbents in low-flow anesthesia.
Hirabayashi G; Mitsui T; Kakinuma T; Ogihara Y; Matsumoto S; Isshiki A; Yasuo W
Ann Clin Lab Sci; 2003; 33(3):313-9. PubMed ID: 12956447
[TBL] [Abstract][Full Text] [Related]
15. Production of compound A under low-flow anesthesia is affected by type of anesthetic machine.
Yamakage M; Kimura A; Chen X; Tsujiguchi N; Kamada Y; Namiki A
Can J Anaesth; 2001 May; 48(5):435-8. PubMed ID: 11394509
[TBL] [Abstract][Full Text] [Related]
16. Quantification of the degradation products of sevoflurane using four brands of CO2 absorbent in a standard anesthetic circuit.
Ikeuchi Y; Bito H; Katoh T; Sato S
J Anesth; 2000; 14(3):143-6. PubMed ID: 14564581
[TBL] [Abstract][Full Text] [Related]
17. Compound A concentrations during low-flow sevoflurane anesthesia correlate directly with the concentration of monovalent bases in carbon dioxide absorbents.
Higuchi H; Adachi Y; Arimura S; Kanno M; Satoh T
Anesth Analg; 2000 Aug; 91(2):434-9. PubMed ID: 10910864
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical evidence against the involvement of cysteine conjugate beta-lyase in compound A nephrotoxicity in rats.
Njoku DB; Pohl LR; Sokoloski EA; Marchick MR; Borkowf CB; Martin JL
Anesthesiology; 1999 Feb; 90(2):458-69. PubMed ID: 9952153
[TBL] [Abstract][Full Text] [Related]
19. Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts.
Morio M; Fujii K; Satoh N; Imai M; Kawakami U; Mizuno T; Kawai Y; Ogasawara Y; Tamura T; Negishi A
Anesthesiology; 1992 Dec; 77(6):1155-64. PubMed ID: 1466466
[TBL] [Abstract][Full Text] [Related]
20. P450-dependent and nonenzymatic human liver microsomal defluorination of fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), a sevoflurane degradation product.
Kharasch ED; Hankins DC
Drug Metab Dispos; 1996 Jun; 24(6):649-54. PubMed ID: 8781780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
